Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

10/11/2015 Natura Bissé in the Barcelona Synchrotron Park 05/11/2015 Two Research Centers Awarded at the UAB University 28/10/2015 How ideas grow, the new Barcelona Synchrotron Park video 20/10/2015 Welcome to Barcelona 08/10/2015 Good News for Two PRUAB Spin-Offs 30/09/2015 BSC-CNS Director, Prof. Valero, Recipient of the Seymour Cray Computer Engineering Award
29 30 31 32 33 34 35 36 37 38 39